GILD - Gilead Nurix extend research pact for two years
2024-04-02 08:20:53 ET
More on Nurix Therapeutics
- Nurix Therapeutics: A Unique Approach To BTK Targeting
- Nurix Therapeutics: Recovering Thanks To ASH, But I Think It's Priced Just Right For Now
- FDA lifts partial hold on Nurix Phase 1 study for NX-2127
- Nurix gets fast track status for leukemia drug candidate
- Seeking Alpha’s Quant Rating on Nurix Therapeutics